Mechanism of action of dnacin B1, a new benzoquinoid antibiotic with antitumor properties.
AUTOR(ES)
Tanida, S
RESUMO
Dnacin B1 preferentially inhibited the incorporation of [3H]thymidine into acid-insoluble fractions in Escherichia coli. At a sublethal concentration, dnacin B1 caused filamentous growth in E. coli and induced prophage lambda. The antibiotic also showed potent bactericidal activity against repair-deficient E. coli strains, such as recA, recB, and polA strains, In in vitro studies, dnacin Ba raised the melting temperatures of various double-stranded DNAs. In addition, the antibiotic showed DNA-cleaving activity against PM2 DNA in the presence of reducing agents, and the activity was suppressed by scavengers for oxygen free radicals and an iron-specific chelator, desferrioxamine E. The stimulation of the generation of superoxide radical by dnacin B1 was confirmed by measuring the reduction of neotetrazolium. Therefore, it can be presumed that the primary cellular target of dnacin B1 is DNA in susceptible cells, and the autooxidation of DNA-bound dnacin B1 causes the generation of oxygen-free radicals that result in the damage of DNA and the inhibition of its synthesis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=185654Documentos Relacionados
- Mechanism of human MxA protein action: variants with changed antiviral properties.
- Quantitative Assay of Pyrazofurin a New Antiviral, Antitumor Antibiotic1
- A new variant of chromosome 3 with unusual staining properties.
- Genetic characterization of frameshift suppressors with new decoding properties.
- Esperamicins, a class of potent antitumor antibiotics: mechanism of action.
